Newsroom :: CytoDyn Inc. (CYDY)

For the latest results and updates on our Phase 2 CRC trial and more, here’s a direct link to our October 19, 2026 Investor Update Webinar

Learn More

CytoDyn Presents Updated Leronlimab Data in Metastatic Colorectal Cancer at ESMO Congress 2026

Oct 26, 2026 8:30am EDT

Press Releases

ESMO Congress 2026 | Leronlimab Shows Early ctDNA and Safety Signals in Metastatic Colorectal Cancer

Oct 25, 2026

Videos

CytoDyn Appoints Robert E. Hoffman as Chief Executive Officer

Oct 19, 2026 4:50pm EDT

Press Releases

Slides presented on October 19, 2026 Investor Update Webinar

Oct 19, 2026

Presentations

CytoDyn to Host Investor Webcast

Oct 15, 2026 8:30am EDT

Press Releases

CytoDyn to Present Updated Data from Phase 2 CLOVER Clinical Study at ESMO Congress 2026

Oct 08, 2026 8:30am EDT

Press Releases

Life Sciences Virtual Investor Forum Presentation (Robert Hoffman)

Sep 17, 2026

Videos

CytoDyn Inc. to Present at the Life Sciences Investor Forum on September 17th

Sep 15, 2026 8:30am EDT

Press Releases

CytoDyn Closes $16.5 Million Financing to Fund Continued Development of Leronlimab

Sep 01, 2026 8:30am EDT

Press Releases

Guest Appearance on The Big Biz Show (Dr. Jacob Lalezari)

Jun 24, 2026

Videos

1
2
3
4
5
6
7
8
9